SMTL ID : 4e28.1

Structure of human thymidylate synthase in inactive conformation with a novel non-peptidic inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

homo-dimer

Ligands

4 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 4 residues within 4Å: Chain A: R.62, R.197, L.201 Chain B: R.188 2 PLIP interactions: 1 interactions with chain A, 1 interactions with chain B Salt bridges: A:R.197, B:R.188 SO4.2: 5 residues within 4Å: Chain A: N.195, H.208, R.227, S.228 Chain B: R.187 5 PLIP interactions: 4 interactions with chain A, 1 interactions with chain B Hydrogen bonds: A:N.195, A:S.228, A:S.228 Salt bridges: A:R.227, B:R.187 SO4.5: 4 residues within 4Å: Chain A: R.188 Chain B: R.62, R.197, L.201 2 PLIP interactions: 1 interactions with chain B, 1 interactions with chain A Salt bridges: B:R.197, A:R.188 SO4.6: 5 residues within 4Å: Chain A: R.187 Chain B: N.195, H.208, R.227, S.228 5 PLIP interactions: 4 interactions with chain B, 1 interactions with chain A Hydrogen bonds: B:N.195, B:S.228, B:S.228 Salt bridges: B:R.227, A:R.187

2 x 0MZ: 2-{(2Z,5S)-4-hydroxy-2-[(2E)-(2-hydroxybenzylidene)hydrazinylidene]-2,5-dihydro-1,3-thiazol-5-yl}-N-[3-(trifluoromethyl)phenyl]acetamide(Non-covalent)

0MZ.3: 14 residues within 4Å: Chain A: K.89, R.90, V.91, F.92, E.99, L.113, K.116, G.144, P.145, G.232, L.233, P.236, F.237 Ligands: 9MZ.4 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:K.89, A:F.92, A:K.116 Hydrogen bonds: A:K.89, A:G.144, A:L.233 0MZ.7: 14 residues within 4Å: Chain B: K.89, R.90, V.91, F.92, E.99, L.113, K.116, G.144, P.145, G.232, L.233, P.236, F.237 Ligands: 9MZ.8 6 PLIP interactions: 6 interactions with chain B Hydrophobic interactions: B:K.89, B:F.92, B:K.116 Hydrogen bonds: B:K.89, B:G.144, B:L.233

2 x 9MZ: 2-{(5S)-2-[(2E)-2-(2-hydroxybenzylidene)hydrazinyl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-[3-(trifluoromethyl)phenyl]acetamide(Non-covalent)

9MZ.4: 14 residues within 4Å: Chain A: K.89, R.90, V.91, F.92, E.99, L.113, G.144, P.145, G.232, L.233, G.234, P.236, F.237 Ligands: 0MZ.3 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:V.91, A:V.91, A:F.92, A:F.237, A:F.237 Hydrogen bonds: A:K.89, A:K.89, A:L.233, A:F.237 9MZ.8: 14 residues within 4Å: Chain B: K.89, R.90, V.91, F.92, E.99, L.113, G.144, P.145, G.232, L.233, G.234, P.236, F.237 Ligands: 0MZ.7 10 PLIP interactions: 10 interactions with chain B Hydrophobic interactions: B:V.91, B:V.91, B:F.92, B:F.237, B:F.237 Hydrogen bonds: B:K.89, B:K.89, B:E.99, B:L.233, B:F.237

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Carosati, E. et al., Inhibitor of ovarian cancer cells growth by virtual screening: a new thiazole derivative targeting human thymidylate synthase. J.Med.Chem. (2012)

Release Date

2012-11-14

Peptides

Thymidylate synthase: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

Thymidylate synthase

Related Entries With Identical Sequence